ArticleCureus2021

Study of Programmed Death Ligand 1 and EGFR/HER2 Expression in Non-Small-Cell Lung Carcinoma With a Clinicopathological Spectrum.

Devina Laishram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.